Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Sertindole
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Serdolect 12mg tablets
040201050BBABAB
|
Serdolect | Sertindole | Central Nervous System | No data available |
|
Serdolect 16mg tablets
040201050BBACAC
|
Serdolect | Sertindole | Central Nervous System | No data available |
|
Serdolect 20mg tablets
040201050BBADAD
|
Serdolect | Sertindole | Central Nervous System | No data available |
|
Serdolect 4mg tablets
040201050BBAAAA
|
Serdolect | Sertindole | Central Nervous System | No data available |
|
Sertindole 12mg tablets
040201050AAABAB
|
Sertindole | Sertindole | Central Nervous System | No data available |
|
Sertindole 16mg tablets
040201050AAACAC
|
Sertindole | Sertindole | Central Nervous System | No data available |
|
Sertindole 20mg tablets
040201050AAADAD
|
Sertindole | Sertindole | Central Nervous System | No data available |
|
Sertindole 4mg tablets
040201050AAAAAA
|
Sertindole | Sertindole | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.